WO2009081360A1 - Contraste d'image par résonance magnétique amélioré par pompage optique avec moment cinétique orbital - Google Patents
Contraste d'image par résonance magnétique amélioré par pompage optique avec moment cinétique orbital Download PDFInfo
- Publication number
- WO2009081360A1 WO2009081360A1 PCT/IB2008/055444 IB2008055444W WO2009081360A1 WO 2009081360 A1 WO2009081360 A1 WO 2009081360A1 IB 2008055444 W IB2008055444 W IB 2008055444W WO 2009081360 A1 WO2009081360 A1 WO 2009081360A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- light
- angular momentum
- magnetic resonance
- catheter
- dipoles
- Prior art date
Links
- 230000002102 hyperpolarization Effects 0.000 title claims description 15
- 238000002595 magnetic resonance imaging Methods 0.000 title abstract description 19
- 239000007787 solid Substances 0.000 title description 4
- 239000007788 liquid Substances 0.000 title description 3
- 230000003287 optical effect Effects 0.000 claims description 22
- 238000003384 imaging method Methods 0.000 claims description 17
- 230000010287 polarization Effects 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 9
- 239000000523 sample Substances 0.000 claims description 6
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 claims description 3
- 239000004973 liquid crystal related substance Substances 0.000 claims description 3
- 229910052710 silicon Inorganic materials 0.000 claims description 3
- 239000010703 silicon Substances 0.000 claims description 3
- 238000001990 intravenous administration Methods 0.000 claims description 2
- 230000001939 inductive effect Effects 0.000 claims 2
- 230000005465 channeling Effects 0.000 claims 1
- 238000001914 filtration Methods 0.000 claims 1
- 230000005855 radiation Effects 0.000 abstract description 5
- 230000005670 electromagnetic radiation Effects 0.000 abstract description 4
- 238000012307 MRI technique Methods 0.000 abstract 1
- 230000008901 benefit Effects 0.000 description 12
- 239000008280 blood Substances 0.000 description 10
- 210000004369 blood Anatomy 0.000 description 10
- 230000003993 interaction Effects 0.000 description 8
- 239000000126 substance Substances 0.000 description 7
- 210000001519 tissue Anatomy 0.000 description 7
- 239000013589 supplement Substances 0.000 description 5
- 239000013598 vector Substances 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 4
- 210000004556 brain Anatomy 0.000 description 4
- 239000002872 contrast media Substances 0.000 description 4
- 210000004204 blood vessel Anatomy 0.000 description 3
- 210000001715 carotid artery Anatomy 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 230000035515 penetration Effects 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- 230000004075 alteration Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000000254 damaging effect Effects 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 229910052756 noble gas Inorganic materials 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 230000003068 static effect Effects 0.000 description 2
- 229910052724 xenon Inorganic materials 0.000 description 2
- FHNFHKCVQCLJFQ-UHFFFAOYSA-N xenon atom Chemical compound [Xe] FHNFHKCVQCLJFQ-UHFFFAOYSA-N 0.000 description 2
- -1 Xenon or Helium Chemical class 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000005013 brain tissue Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 230000001427 coherent effect Effects 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000002059 diagnostic imaging Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000005672 electromagnetic field Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000001105 femoral artery Anatomy 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000001307 helium Substances 0.000 description 1
- 229910052734 helium Inorganic materials 0.000 description 1
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 150000002835 noble gases Chemical class 0.000 description 1
- 238000012576 optical tweezer Methods 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 230000012846 protein folding Effects 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- 238000001429 visible spectrum Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G02—OPTICS
- G02B—OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
- G02B27/00—Optical systems or apparatus not provided for by any of the groups G02B1/00 - G02B26/00, G02B30/00
- G02B27/28—Optical systems or apparatus not provided for by any of the groups G02B1/00 - G02B26/00, G02B30/00 for polarising
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N24/00—Investigating or analyzing materials by the use of nuclear magnetic resonance, electron paramagnetic resonance or other spin effects
- G01N24/08—Investigating or analyzing materials by the use of nuclear magnetic resonance, electron paramagnetic resonance or other spin effects by using nuclear magnetic resonance
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R33/00—Arrangements or instruments for measuring magnetic variables
- G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
- G01R33/28—Details of apparatus provided for in groups G01R33/44 - G01R33/64
- G01R33/282—Means specially adapted for hyperpolarisation or for hyperpolarised contrast agents, e.g. for the generation of hyperpolarised gases using optical pumping cells, for storing hyperpolarised contrast agents or for the determination of the polarisation of a hyperpolarised contrast agent
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R33/00—Arrangements or instruments for measuring magnetic variables
- G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
- G01R33/28—Details of apparatus provided for in groups G01R33/44 - G01R33/64
- G01R33/285—Invasive instruments, e.g. catheters or biopsy needles, specially adapted for tracking, guiding or visualization by NMR
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R33/00—Arrangements or instruments for measuring magnetic variables
- G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
- G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
- G01R33/48—NMR imaging systems
- G01R33/54—Signal processing systems, e.g. using pulse sequences ; Generation or control of pulse sequences; Operator console
- G01R33/56—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution
- G01R33/5601—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution involving use of a contrast agent for contrast manipulation, e.g. a paramagnetic, super-paramagnetic, ferromagnetic or hyperpolarised contrast agent
-
- G—PHYSICS
- G02—OPTICS
- G02B—OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
- G02B27/00—Optical systems or apparatus not provided for by any of the groups G02B1/00 - G02B26/00, G02B30/00
- G02B27/42—Diffraction optics, i.e. systems including a diffractive element being designed for providing a diffractive effect
- G02B27/46—Systems using spatial filters
Definitions
- the present application relates to the diagnostic imaging arts. It finds 5 particular application in magnetic resonance imaging of regions near the surface of a subject's skin or accessible with a probe or catheter, and will be described with particular reference thereto. It is to be appreciated, however, that it is also applicable to other regions or areas, contrast enhanced imaging, spectroscopy and is not limited to the aforementioned applications.
- MRI magnetic resonance imaging
- tissue components in the characterization and differentiation of soft tissues.
- Other applications include fluid chemical analysis of small molecules and biomolecules (e.g. protein-ligand interactions, protein folding, protein structure validation, and protein structure determination), solid state analysis (structural), dynamics of time- variable systems, and the like.
- Micro MRI systems exist that overcome some of these drawbacks.
- permanent magnets on the tip of a catheter generate a static magnetic field at the catheter tip.
- a micro MRI system also has a high quality receiving coil built into the tip, such as a Helmholtz micro coil. This allows for local imaging of blood vessels without the need for external magnets or coils.
- Gradient coils facilitate Fourier images or point- by-point imaging/analysis to be performed without gradient coils.
- the present application provides a new and improved optical polarization device which overcomes the above-referenced problems and others.
- a light-based hyperpolarization device emits light.
- a phase hologram imparts orbital angular momentum to the light.
- a spatial filter filters out a portion of the light and allows a portion of the light with a pre-determined amount of orbital angular momentum to pass.
- At least one optical element directs the light that passes the spatial filter to a region of interest to be hyperpolarized.
- a magnetic resonance system including a light-based hyperpolarization device that polarizes a selected dipole PH009189
- An RF system induces resonance in the polarized dipoles and receives resonance signals.
- a surface probe In accordance with another aspect, a surface probe is provided.
- a light output unit directs light to penetrate tissue of a patient.
- a light-based hyperpolarization system imparts orbital angular momentum to generated light. The light to which orbital angular momentum has been imparted is discharged through the light output unit to polarize selected dipoles in the patient.
- a catheter In accordance with another aspect, a catheter is provided. An elongated portion terminates in a working end configured to be inserted in a patient. A light-based hyperpolarization system imparts orbital angular momentum to generated light. The light to which orbital angular momentum has been imparted is discharged through the light output unit to polarize selected dipoles in the patient.
- a method of resonance imaging is provided.
- a selected dipole is polarized via transferred orbital angular momentum.
- Resonance is induced in the polarized dipoles.
- Resonance signals are received.
- One advantage is that blood can be more effectively imaged using nuclear resonance without aid of chemical contrast agents.
- Another advantage lies in improved access to the subject. Another advantage resides in lower cost.
- Another advantage lies in improved resonance signal strengths.
- Another advantage lies in improved resolution.
- Another advantage of some embodiments is the elimination of large magnetic fields and the associated hardware for generating them, etc. Still further advantages of the present invention will be appreciated by those of ordinary skill in the art upon reading and understand the following detailed description.
- FIGURE 1 is a diagrammatic illustration of a molecule interacting with an incident photon
- FIGURE 2 is an optical diagram of a device for generating polarized light beams endowed with orbital angular momentum, in accordance with the present application;
- FIGURE 3 is an enlarged view of a computer generated phase hologram for endowing incident light with orbital angular momentum, in accordance with the present application;
- FIGURE 4 is a diffraction projection of a light beam after it passes through the phase hologram of FIGURE 3;
- FIGURE 5 depicts a spatial filter overlaid on the diffraction projection of FIGURE 4;
- FIGURE 6 is a diagrammatic illustration of a magnetic resonance imaging apparatus in accordance with the present application.
- FIGURE 7 is a cutaway view of a catheter that carries orbital angular momentum-endowed light, the catheter being capable of being inserted into a patient, in accordance with the present application.
- Orbital angular momentum is an intrinsic property of all azimuthal phase-bearing light, independent of the choice of axis about which the OAM is defined.
- OAM can be transferred from the light to the matter.
- An analysis of electromagnetic fields shows that there is a flow of electromagnetic energy with one component that travels along the vector of the beam propagation, and a second component that rotates about the axis of the beam propagation.
- the second component is proportional to the angular change of the potential vector around the beam propagation. This is significant because the rotational energy flow is proportional to /, the OAM value, and the rotational energy transferred to molecules with which the light interacts is increased with the value of the OAM.
- Light-carrying spin and OAM is absorbed by molecules. Since angular momentum is a conserved quantity, the total angular momentum of the system (both the radiation and the matter) is not changed during absorption and emission of radiation. When a photon is absorbed by an atom, its angular momentum is transferred to the atom. The resulting angular momentum of the atom is then equal to the vector sum of its initial angular momentum plus the angular momentum of the absorbed photon.
- the Applicant supplements or replaces the function of the Bo field in conventional MRI by electromagnetic radiation endowed with OAM, as described above.
- FIGURE 2 an exemplary arrangement of optical elements is shown for endowing light with OAM. It is to be understood that any PH009189
- the described embodiment uses visible light, which interacts with the molecules of interest, and has no damaging effect on living tissue. Light/radiation above or below the visible spectrum, however, is also contemplated.
- a white light source 22 produces visible white light that is sent to a beam expander 24. In alternate embodiments, the frequency and coherence of the light source can be used to manipulate the signal if chosen carefully, but such precision is not essential.
- the beam expander includes an entrance collimator 25i for collimating the emitted light into a narrow beam, a concave or dispersing lens 25 2 , a refocusing lens 25 3 , and an exit collimator 25 4 through which the least dispersed frequencies of light are emitted. In one embodiment, the exit collimator 25 4 narrows the beam to a 1 mm beam.
- the light beam is circularly polarized by a linear polarizer 26 followed by a quarter wave plate 28.
- the linear polarizer 26 takes unpolarized light and gives it a single linear polarization.
- the quarter wave plate 28 shifts the phase of the linearly polarized light by 1 A wavelength, circularly polarizing it. Using circularly polarized light is not essential, but it has the added advantage of polarizing electrons.
- phase hologram 30 An example of a phase hologram 30 is depicted in FIGURE 3.
- the phase hologram 30 imparts OAM and spin to an incident beam.
- the value "/" of the OAM is a parameter dependent on the phase hologram 30.
- the phase hologram 30 is a computer generated element and is physically embodied in a spatial light modulator, such as a liquid crystal on silicon (LCoS) panel, 1280x720 pixels, 20x20 ⁇ m 2 , with a 1 ⁇ m cell gap.
- the phase hologram 30 could be embodied in other optics, such as combinations of cylindrical lenses or wave plates.
- the spatial light modulator has the added advantage of being changeable, even during a scan, with a simple command to the LCoS panel.
- the bright spot (Airy disk) 32 in the middle represents the 0 th order diffraction, in this case, that is light with no OAM.
- the circles 34 adjacent the bright spot 32 represent diffracted beams of different harmonics that carry OAM. This distribution results because the probability of OAM interaction with molecules falls to zero at points far from the center of the light beam or in the center of the light beam. The greatest chance for interaction occurs on a radius corresponding to the maximum field distribution, that is, for circles close to the Airy disk. Therefore, the maximum probability of OAM interaction is obtained with a light beam with a radius as close as possible to the Airy disk radius.
- a spatial filter 36 is placed after the holographic plate to selectively pass only light with OAM and spin.
- An example of such a filter is shown in FIGURE 5.
- the 0 th order spot 32 always appears in a predictable spot, and thus can be blocked.
- the filter 36 allows light with OAM to pass. Note that the filter 36 also blocks the circles that occur below and to the right of the bright spot 32. Since OAM of the system is conserved, this light has OAM that is equal and opposite to the OAM of the light that the filter 36 allows to pass. It would be counterproductive to let all of the light pass, because the net OAM transferred to the target molecule would be zero. Thus, the filter 36 only allows light having OAM of one polarity to pass.
- the diffracted beams carrying OAM are collected using concave mirrors 38 and focused to the region of interest with a fast microscope objective lens 40.
- the mirrors 38 may not be necessary if coherent light were being used.
- a faster lens (having a high f-number) is desirable to satisfy the condition of a beam waist as close as possible to the size of the Airy disk.
- the lens 40 may be replaced or supplemented with an alternative light guide or fiber optics.
- the polarized light is used to supplement the B 0 field of an existing scanner.
- the light is emitted parallel to the B 0 field, so that the effects complement each other, that is, the nuclei are aligned in the same direction due to both the B 0 field and the polarized light.
- Traditional spatial encoding and RF excitation can be used, but with the optical alignment, the resonance signal can be seven to eight orders of magnitude stronger, leading to increased signal to noise ratio, better signal strength, and improved resolution, on the order of micrometers.
- the PH009189 the PH009189
- polarized light beam is applied along a direction other than parallel to the B 0 field, to produce concurrent dipoles with different relaxation orientations.
- the typical B 0 field is replaced entirely by optical perturbation.
- the large, complex main magnet is eliminated, greatly freeing up space and making the subject more accessible.
- resonance signals would only be received from dipoles accessible by the optical delivery system.
- Spatial encoding is achieved, for example, by gradient magnetic fields produced by weaker, homogeneous magnets.
- spatial encoding is achieved optically. Polarized light along one axis serves to align the dipoles along a single direction, while an array of light generators along another axis perform the spatial encoding. The light is used to spatially encode the resonance by phase encoding and frequency encoding. Frequency encoding is provided by magnets or by light.
- the light emitting system previously described may be embodied in a needle or catheter 68 in FIGURE 6 and inserted directly into the bloodstream.
- the light source 22 is conveniently located outside of the intravenous device and fiber optics is used to channel the light thereto.
- the catheter 68 is then inserted into the subject, such as through the femoral artery, and advanced to the region or anatomy of interest.
- the light aligns dipoles in illuminated vessel walls or other adjacent tissues analogous to a conventional B 0 field.
- the aligned dipoles are caused to resonate by the application of RF signals by an RF coil in the tip of the catheter 68 or by external RF coils.
- the induced resonance signals are received by the RF coils in the tip of the catheter for a high signal-to-noise ratio.
- External RF receive coils e.g. surface coils are also contemplated.
- the resonance can be spatially encoded in various ways.
- the resonance is excited in and detected from a single voxel at a time.
- external or at-the-tip gradient magnetic field coils phase- and frequency-encode the resonance.
- a permanent magnet or magnetic field coil adjacent the tip encodes frequency and the OAM enhanced light is used for phase encoding.
- a very low field magnet provides a weak Bo field aligned with the OAM-endowed induced polarization.
- the B 0 field determines the resonance frequency. The higher the Bo field, the higher the resonance frequency. High PH009189
- B 0 fields generally have high associated magnet costs and larger magnets that inhibit patient access.
- blood passing by the light emitter at the tip of the catheter 68 or a surface probe 66 is aligned, particularly hyperpolarized, and it can be imaged as it flows to a downstream portion of the body.
- the light source illuminates blood flowing through the carotid artery
- the hyperpolarized blood exhibits high signal strengths in the blood vessels in the brain.
- the carotid artery passes close to the surface, it can be illuminated from the surface without using an invasive procedure such as a catheter.
- the polarized light can be used in lieu of, or to supplement traditional chemical contrast in a conventional MRI system.
- polarized light is not as time-sensitive as some chemical contrast agents, as the transit time to the patient and ultimately to the region of interest would not be critical. Also, chemical contrast agents carry the disadvantage of being hard on the patient's kidneys and liver, and elimination of the use of such chemical contrast agents would therefore be beneficial.
- OAM organic metal-oxide-semiconductor
- Infrared light can be used to increase light penetration, for example, to illuminate sub-dermal structures, but at the cost of interaction strength.
- OAM can be imparted to any electromagnetic wave, not just visible light. Using shorter wavelengths would bring the advantage of having greater sub-dermal penetration, but also carrying with it the disadvantage that penetrating radiation is potentially damaging to tissue.
- the OAM-endowed light- emitting device as described above can be used in conjunction with a magnetic resonance scanner 40.
- the magnetic resonance scanner 40 can be an open field system (open MRI system) that includes a vertical main magnet assembly 42.
- the main magnet assembly 42 produces a substantially constant main magnetic field oriented along a vertical axis of an imaging region.
- a vertical main magnet assembly 42 is illustrated, it is to be PH009189
- a gradient coil assembly 44 produces magnetic field gradients in the imaging region for spatially encoding the main magnetic field.
- the magnetic field gradient coil assembly 44 includes coil segments configured to produce magnetic field gradient pulses in three orthogonal directions, typically longitudinal or z, transverse or x, and vertical or y directions. Both the main magnet assembly 42 and the gradient field assembly 44 in some embodiments are used along with optical polarization.
- a radio frequency coil assembly 46 (illustrated as a head coil, although surface and whole body coils are also contemplated) generates radio frequency pulses for exciting resonance in dipoles of the subject.
- the radio frequency coil assembly 46 also serves to detect resonance signals emanating from the imaging region.
- the radio frequency coil assembly 46 can be used to supplement optical perturbation of previously established polarization.
- Gradient pulse amplifiers 48 deliver controlled electrical currents to the magnetic field gradient assembly 44 to produce selected magnetic field gradients.
- a radio frequency transmitter 50 preferably digital, applies radio frequency pulses or pulse packets to the radio frequency coil assembly 46 to excite selected resonance.
- a radio frequency receiver 52 is coupled to the coil assembly 46 or separate receive coils to receive and demodulate the induced resonance signals.
- a sequence controller 54 communicates with the gradient amplifiers 48 and the radio frequency transmitter 50 to supplement the optical manipulation of the region of interest.
- the sequence controller 54 may, for example, produce selected repeated echo steady-state, or other resonance sequences, spatially encode such resonances, selectively manipulate or spoil resonances, or otherwise generate selected magnetic resonance signals characteristic of the subject.
- the generated resonance signals are detected by the RF coil assembly 46, communicated to the radio frequency receiver 52, demodulated and stored in a k-space memory 56.
- the imaging data is reconstructed by a reconstruction processor 58 to produce one or more image representations that are stored in an image memory 60.
- the reconstruction processor 58 performs an inverse Fourier transform reconstruction. PH009189
- the resultant image representation(s) is processed by a video processor 62 and displayed on a user interface 64 equipped with a human readable display.
- the interface 64 is preferably a personal computer or workstation. Rather than producing a video image, the image representation can be processed by a printer driver and printed, transmitted over a computer network or the Internet, or the like.
- the user interface 64 also allows a radiologist or other operator to communicate with the sequence controller 54 to select magnetic resonance imaging sequences, modify imaging sequences, execute imaging sequences, and so forth.
- a surface probe device 66 that carries the optical device depicted in FIGURE 2 is pressed against the carotid artery(s) where it is sufficiently close that the optical light will penetrate to the blood inside.
- the optical device can be used to align or hyperpolarize the nuclei of molecules in the blood flowing past the device. These molecules can then be imaged with the device 40 as they flow through the subject's bloodstream.
- a series of volume images of the brain are generated as the hyperpolarized blood flows into the brain and/or as it washes out.
- a single volume image is generated or selected, which illustrates the blood flow in the brain. The images can illustrate penetration of blood into brain tissue, arterial flow, venous flow, etc.
- an inserted catheter or needle probe, as described above, is used to hyperpolarize blood upstream from a region of interest.
- the catheter 68 and the main magnets 42 can work together to align the dipoles of interest, the gradient coil assembly 44 can provide spatial encoding, and the RF coils system 46 can excite and receive resonance.
- the hyperpolarizing device is contained entirely within the catheter 68 system.
- the catheter 68 includes an elongated portion 70 and a working end 72 configured for insertion into a patient.
- the elongated portion 70 includes fiber optics or other light guides to transmit light from the light source 22 to the working end 72.
- the catheter 68 includes the magnetic elements necessary for magnetic resonance imaging at the working end; the working end includes a magnet 74 for producing a substantially uniform magnetic field at the working end 72 of PH009189
- a gradient magnetic coil 76 for encoding the main magnetic field with gradient fields
- an RF coil 78 for exciting and receiving magnetic resonance.
- polarized light coming through the elongated portion 70 encounters a partially mirrored plate 80 that allows a portion of light to pass to a first objective lens 82. Another portion of light is reflected to a first mirror 84 and on to a second mirror 86 where it then passes through a second objective lens 88, which is oriented orthogonally to the first objective lens. Other optical orientations are certainly possible to arrive at the same result and are also contemplated.
- a mechanical shutter 90 may be provided so that the orthogonally oriented light may be selectively blocked when it is not desired.
- light from the second objective lens 86 can be used to selectively optically manipulate dipoles polarized by light from the first objective lens 82.
Landscapes
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- High Energy & Nuclear Physics (AREA)
- Condensed Matter Physics & Semiconductors (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Optics & Photonics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Magnetic Resonance Imaging Apparatus (AREA)
Abstract
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP08863841A EP2225551A1 (fr) | 2007-12-20 | 2008-12-19 | Contraste d'image par résonance magnétique amélioré par pompage optique avec moment cinétique orbital |
US12/808,385 US8765099B2 (en) | 1996-04-08 | 2008-12-19 | Magnetic resonance imaging hyperpolarization of liquids or solids by light with orbital angular momentum |
CN200880121251.8A CN101971011B (zh) | 2007-12-20 | 2008-12-19 | 利用通过具有轨道角动量的光超极化液体或固体的磁共振成像 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US1521007P | 2007-12-20 | 2007-12-20 | |
US60/015,210 | 2007-12-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2009081360A1 true WO2009081360A1 (fr) | 2009-07-02 |
Family
ID=40548508
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2008/055444 WO2009081360A1 (fr) | 1996-04-08 | 2008-12-19 | Contraste d'image par résonance magnétique amélioré par pompage optique avec moment cinétique orbital |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP2225551A1 (fr) |
CN (1) | CN101971011B (fr) |
WO (1) | WO2009081360A1 (fr) |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010064155A1 (fr) * | 2008-12-05 | 2010-06-10 | Koninklijke Philips Electronics, N.V. | Localisation par dispositifs actifs utilisant une lumière avec moment angulaire orbital pour induire une irm hyperpolarisée |
WO2010146502A1 (fr) * | 2009-06-19 | 2010-12-23 | Koninklijke Philips Electronics N.V. | Imagerie par resonance magnetique avec hyperpolarisation au moyen de photons avec moment angulaire orbital |
WO2010146520A1 (fr) * | 2009-06-19 | 2010-12-23 | Koninklijke Philips Electronics N.V. | Dispositif d'hyperpolarisation utilisant des photons à moment cinétique orbital |
WO2010146517A1 (fr) * | 2009-06-19 | 2010-12-23 | Koninklijke Philips Electronics N.V. | Thermométrie par irm associée à un dispositif d'hyperpolarisation utilisant des photons à moment cinétique orbital |
WO2011018719A1 (fr) * | 2009-08-11 | 2011-02-17 | Koninklijke Philips Electronics, N.V. | Imagerie par résonance magnétique par hyperpolarisation transversale directe employant une lumière dotée de moment cinétique orbital |
WO2011018718A1 (fr) * | 2009-08-11 | 2011-02-17 | Koninklijke Philips Electronics, N.V. | Mesure de ph par résonance magnétique employant une lumière dotée de moment cinétique orbital |
JP2011510288A (ja) * | 2008-01-18 | 2011-03-31 | コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ | 軌道角運動量を伴う光を用いる核磁気共鳴分光学 |
WO2011101765A1 (fr) | 2010-02-16 | 2011-08-25 | Koninklijke Philips Electronics N.V. | Hyperpolarisation optique |
WO2011132092A1 (fr) | 2010-04-22 | 2011-10-27 | Koninklijke Philips Electronics N.V. | Magnétomètre à résonance magnétique nucléaire employant une hyperpolarisation induite optiquement |
WO2012172471A2 (fr) | 2011-06-15 | 2012-12-20 | Koninklijke Philips Electronics N.V. | Hyperpolarisation induite par moment angulaire optique dans des applications interventionnelles |
WO2012176181A1 (fr) | 2011-06-23 | 2012-12-27 | Koninklijke Philips Electronics N.V. | Radiothérapie guidée par l'image |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015044062A1 (fr) * | 2013-09-30 | 2015-04-02 | Koninklijke Philips N.V. | Moyen de création d'expérience ambiante |
CN104792412B (zh) * | 2015-04-22 | 2017-01-25 | 东南大学 | 一种检测光场轨道角动量的装置及方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1224502A (zh) * | 1996-03-29 | 1999-07-28 | 劳伦斯·伯克利国家实验室 | 利用超极化惰性气体对于核磁共振和磁共振成象质量的提高 |
US6278893B1 (en) * | 1998-01-05 | 2001-08-21 | Nycomed Imaging As | Method of magnetic resonance imaging of a sample with ex vivo polarization of an MR imaging agent |
-
2008
- 2008-12-19 CN CN200880121251.8A patent/CN101971011B/zh not_active Expired - Fee Related
- 2008-12-19 EP EP08863841A patent/EP2225551A1/fr not_active Withdrawn
- 2008-12-19 WO PCT/IB2008/055444 patent/WO2009081360A1/fr active Application Filing
Non-Patent Citations (5)
Title |
---|
BINGELYTE V ET AL: "Optically controlled three-dimensional rotation of microscopic objects", APPLIED PHYSICS LETTERS, AIP, AMERICAN INSTITUTE OF PHYSICS, MELVILLE, NY, US, vol. 82, no. 5, 3 February 2003 (2003-02-03), pages 829 - 831, XP012034725, ISSN: 0003-6951 * |
ELGORT D R ET AL: "Direct Optical Hyperpolarization of Liquids", PROCEEDINGS OF THE INTERNATIONAL SOCIETY FOR MAGNETIC RESONANCE IN MEDICINE, 16TH SCIENTIFIC MEETING AND EXHIBITION, TORONTO, ONTARIO, CANADA, 3-9 MAY 2008, INTERNATIONAL SOCIETY FOR MAGNETIC RESONANCE IN MEDICINE, US, 3 May 2008 (2008-05-03), pages 3200, XP007908368 * |
JONATHAN LEACH ET AL: "Observation of chromatic effects near a white-light vortex; Observation of chromatic effects near a white-light vortex", NEW JOURNAL OF PHYSICS, INSTITUTE OF PHYSICS PUBLISHING, BRISTOL, GB, vol. 5, no. 1, 1 November 2003 (2003-11-01), pages 154 - 154, XP020080351, ISSN: 1367-2630 * |
YOKO MIYAMOTO ET AL: "Detection of orbital angular momentum superposition photon states using hologram and path interferometer", LASERS AND ELECTRO-OPTICS, 2007 AND THE INTERNATIONAL QUANTUM ELECTRON ICS CONFERENCE. CLEOE-IQEC 2007. EUROPEAN CONFERENCE ON, IEEE, PI, 1 June 2007 (2007-06-01), pages 1 - 1, XP031163368, ISBN: 978-1-4244-0930-3 * |
ZDENEK BOUCHAL ET AL: "Selective excitation of vortex fibre modes using a spatial light modulator; Selective excitation of vortex fibre modes using a spatial light modulator", NEW JOURNAL OF PHYSICS, INSTITUTE OF PHYSICS PUBLISHING, BRISTOL, GB, vol. 7, no. 1, 1 May 2005 (2005-05-01), pages 125 - 125, XP020092848, ISSN: 1367-2630 * |
Cited By (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2011510288A (ja) * | 2008-01-18 | 2011-03-31 | コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ | 軌道角運動量を伴う光を用いる核磁気共鳴分光学 |
CN102238923A (zh) * | 2008-12-05 | 2011-11-09 | 皇家飞利浦电子股份有限公司 | 使用具有轨道角动量的光诱发超极化mri的有源装置追踪 |
US8611982B2 (en) | 2008-12-05 | 2013-12-17 | Koninklijke Philips N.V. | Active device tracking using light with orbital angular momentum to hyperpolarized MRI |
WO2010064155A1 (fr) * | 2008-12-05 | 2010-06-10 | Koninklijke Philips Electronics, N.V. | Localisation par dispositifs actifs utilisant une lumière avec moment angulaire orbital pour induire une irm hyperpolarisée |
WO2010146502A1 (fr) * | 2009-06-19 | 2010-12-23 | Koninklijke Philips Electronics N.V. | Imagerie par resonance magnetique avec hyperpolarisation au moyen de photons avec moment angulaire orbital |
WO2010146520A1 (fr) * | 2009-06-19 | 2010-12-23 | Koninklijke Philips Electronics N.V. | Dispositif d'hyperpolarisation utilisant des photons à moment cinétique orbital |
WO2010146517A1 (fr) * | 2009-06-19 | 2010-12-23 | Koninklijke Philips Electronics N.V. | Thermométrie par irm associée à un dispositif d'hyperpolarisation utilisant des photons à moment cinétique orbital |
US8636980B2 (en) | 2009-06-19 | 2014-01-28 | Koninklijke Philips N.V. | MRI thermometry combined with hyperpolarisation device using photons with orbital angular momentum |
CN102472806A (zh) * | 2009-08-11 | 2012-05-23 | 皇家飞利浦电子股份有限公司 | 利用被赋予轨道角动量的光进行磁共振pH测量 |
CN102472715A (zh) * | 2009-08-11 | 2012-05-23 | 皇家飞利浦电子股份有限公司 | 利用被赋予轨道角动量的光通过直接横向超极化进行 mri |
WO2011018718A1 (fr) * | 2009-08-11 | 2011-02-17 | Koninklijke Philips Electronics, N.V. | Mesure de ph par résonance magnétique employant une lumière dotée de moment cinétique orbital |
WO2011018719A1 (fr) * | 2009-08-11 | 2011-02-17 | Koninklijke Philips Electronics, N.V. | Imagerie par résonance magnétique par hyperpolarisation transversale directe employant une lumière dotée de moment cinétique orbital |
WO2011101765A1 (fr) | 2010-02-16 | 2011-08-25 | Koninklijke Philips Electronics N.V. | Hyperpolarisation optique |
CN102762996A (zh) * | 2010-02-16 | 2012-10-31 | 皇家飞利浦电子股份有限公司 | 利用被赋予轨道角动量的光的光学超极化 |
JP2013519419A (ja) * | 2010-02-16 | 2013-05-30 | コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ | 軌道角運動量を持つ光を用いる光学過分極 |
US9222995B2 (en) | 2010-02-16 | 2015-12-29 | Koninklijke Philips N.V. | Apparatus and method for dispensing a hyperpolarized fluid |
WO2011132092A1 (fr) | 2010-04-22 | 2011-10-27 | Koninklijke Philips Electronics N.V. | Magnétomètre à résonance magnétique nucléaire employant une hyperpolarisation induite optiquement |
CN102859384A (zh) * | 2010-04-22 | 2013-01-02 | 皇家飞利浦电子股份有限公司 | 利用光诱发的超极化的核磁共振磁力计 |
WO2012172471A2 (fr) | 2011-06-15 | 2012-12-20 | Koninklijke Philips Electronics N.V. | Hyperpolarisation induite par moment angulaire optique dans des applications interventionnelles |
WO2012172471A3 (fr) * | 2011-06-15 | 2013-03-07 | Koninklijke Philips Electronics N.V. | Hyperpolarisation induite par moment angulaire optique dans des applications interventionnelles |
WO2012176181A1 (fr) | 2011-06-23 | 2012-12-27 | Koninklijke Philips Electronics N.V. | Radiothérapie guidée par l'image |
Also Published As
Publication number | Publication date |
---|---|
EP2225551A1 (fr) | 2010-09-08 |
CN101971011A (zh) | 2011-02-09 |
CN101971011B (zh) | 2014-03-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8765099B2 (en) | Magnetic resonance imaging hyperpolarization of liquids or solids by light with orbital angular momentum | |
WO2009081360A1 (fr) | Contraste d'image par résonance magnétique amélioré par pompage optique avec moment cinétique orbital | |
RU2526895C2 (ru) | Мрт с гиперполяризационным устройством, использующим фотоны с орбитальным угловым моментом | |
US8508222B2 (en) | Nuclear magnetic resonance spectroscopy using light with orbital angular momentum | |
US8636980B2 (en) | MRI thermometry combined with hyperpolarisation device using photons with orbital angular momentum | |
Moonen et al. | Comparison of single‐shot localization methods (STEAM and PRESS) for in vivo proton NMR spectroscopy | |
US20120150019A1 (en) | Mri by direct transverse hyperpolarization using light endowed with orbital angular momentum | |
EP2235510A1 (fr) | Analyse d'échantillon à base de micro-spectroscopie rmn | |
US20120081120A1 (en) | Hyperpolarisation device using photons with orbital angular momentum | |
JPH03506028A (ja) | 安定なフリーラジカル含有コントラスト媒体 | |
US20120126810A1 (en) | Magnetic resonance ph measurements using light endowed with orbital angular momentum | |
WO2009090609A1 (fr) | Procédé de mesure utilisant la spectroscopie par résonance magnétique nucléaire et lumière à moment angulaire orbital | |
US20140097847A1 (en) | Optical angular momentum induced hyperpolarisation in interventional applications | |
US11519983B2 (en) | Quantum sensor-based receiving unit configured for acquiring MR signals | |
US20060232272A1 (en) | Imaging apparatus and method | |
Wieteska et al. | Increasing the signal to noise ratio in low-field mr scanner at department of nuclear and medical electronics | |
Chowdhury | Enabling clinical Hyperpolarised 13C-MR cancer imaging through phantom development, pulse sequence optimisation and quantitative image processing | |
Keevil | in medicine | |
Hausser et al. | NMR tomography | |
Oppelt | Physical principles and technology of magnetic resonance imaging | |
Briand | Spatially localized nuclear magnetic resonance | |
Oppelt | Magnetic Resonance Tomography—Imaging with a Nonlinear System | |
Bethge et al. | Magnetic Resonance in Medical Diagnostics |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200880121251.8 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08863841 Country of ref document: EP Kind code of ref document: A1 |
|
REEP | Request for entry into the european phase |
Ref document number: 2008863841 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2008863841 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12808385 Country of ref document: US |
|
NENP | Non-entry into the national phase |
Ref country code: DE |